The Lord-Lieutenant of South Glamorgan Presents CatSci with The Queen’s Award and Opens their Oligonucleotide Laboratory 

Apr 3rd 2023
The Lord-Lieutenant of South Glamorgan Presents CatSci with The Queen’s Award and Opens their Oligonucleotide Laboratory 

CatSci Ltd were honoured to welcome His Majesty’s Lord-Lieutenant of South Glamorgan, Mrs Morfudd Meredith, to their Cardiff Site on Wednesday 29th March 2023. This special visit was to commemorate CatSci’s monumental achievement in winning The Queen’s Award for Enterprise: International Trade 2022. Mrs Meredith presented CatSci with their esteemed award, and also officially opened their new state-of-the-art Oligonucleotide laboratory

Winning The Queen’s Award for Enterprise 2022 was a tremendous achievement for CatSci. It reflects the hard work, talent and commitment of the whole CatSci team. The esteemed award is also a testament to CatSci’s innovative export strategy and cutting-edge scientific expertise; it solidifies their position as a dynamic, agile and world-class innovation partner for medicines development. After presenting The Queen’s Award, the Lord-Lieutenant discussed with staff CatSci’s impressive contribution to the growing Welsh STEM sector and its significant impact on expediting the delivery of life-changing medicines to patients worldwide.  

As well as presenting CatSci with their award, the Lord-Lieutenant also opened CatSci’s state-of-the-art Oligonucleotide laboratory, based in their Cardiff HQ. Oligonucleotides are an emerging modality offering new therapeutic opportunities to treat previously unmet patients’ needs. The laboratory is kitted with the latest high-end equipment; CatSci’s new offering will accelerate the development and manufacture of these complex molecules, and answer more of their customers’ dynamic portfolio demands.   

CatSci’s Oligonucleotide R&D and Manufacturing offering will be led by Dr Nigel Richardson, CatSci’s Director of New Modalities. Nigel has decades of experience in the oligonucleotides space, having previously led GSK’s oligonucleotide therapy for Duchenne Muscular Dystrophy into the final stages of development and regulatory submission.  

His Majesty’s Lord-Lieutenant said of the visit: “Warmest congratulations to CatSci on their outstanding achievement in winning the prestigious Queen’s Award for Enterprise in the International Trade category in the year that our late monarch Queen Elizabeth II marked her historic 70 year reign. This award is considered one of the highest accolades to be bestowed on a UK business and is thoroughly deserved.”  

Dr Ross Burn, CatSci’s CEO and Co-Founder, said of the Lord Lieutenant’s visit: “It was a great honour to both CatSci and myself to have His Majesty’s Lord-Lieutenant of South Glamorgan to present us with The Queens Award and open our new oligonucleotides laboratory at our Cardiff Site. I am incredibly proud of the hard work of the whole team in receiving The Queen’s Award, the Lord-Lieutenant could see first-hand the excellent work that is being delivered by our talented team, as well as their relentless efforts in accelerating the development of best-in-class therapeutics.”  

Dr Nigel Richardson, CatSci’s Director of New Modalities and leader of their oligonucleotides team, added: “I am delighted that our Oligonucleotide laboratory has been officially opened, and it is a great honour for it to be opened by His Majesty’s Lord-Lieutenant. I am excited to be able to offer our customers our Oligonucleotide R&D and Manufacture services, and together treat previously untreatable illnesses and deliver life-changing medicines to patients in need.”